9/11 Breast Cancer
Breast cancer is one of the most common cancers found among 9/11 female first responders, downtown workers and downtown residents. Turley Hansen represents many breast cancer survivors in claims before the 9/11 Victim Compensation Fund.
About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of their lifetime. Women exposed to the toxins in downtown Manhattan have a particularly high risk of developing breast cancer. The Zadroga Act covers invasive ductal carcinomas (about 80% of all breast cancers), ductal carcinoma in situ (the most common type of non-invasive breast cancer) and male breast cancer.
Surgery, either lumpectomy or mastectomy (partial, total, modified radical), are common starting points of treatment for breast cancer. Surgery may be followed up by chemotherapy, radiation therapy and hormonal therapy. New immunotherapy clinical trials for breast cancer patients are potentially offering new weapons to fight breast cancer.
Should you have questions about medical care or an award for breast cancer from the 9/11 Victim Compensation Fund, please call us at 1-855-982-4636.